¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05
±³À°ÀÏÀÚ : 2022-03-05
±³À°Àå¼Ò : ºÎ»êBPEX  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  
À̸ÞÀÏ : office@thyroid.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 08:30~08:50 Role of Serum TSH in Active Surveillance of PTMC  ±èÇýÀÎ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 08:50~09:10 Tumor Volume Doubling Time in Active Surveillance of PTMC  ±è¿ø¹è(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 09:10~09:30 Interim Analysis of MAeSTro  ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 09:30~09:40 ÅäÀÇ  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 09:40~10:00 Characterizing Dedifferentiation of Thyroid Cancer by Single Cell RNA Seqencing  ¹ÚÁöȯ(GIST) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 10:00~10:20 Diagnositc Approach in Thyroid Disease using Biometric Wearable Devices  ¹®ÀçÈÆ(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 10:20~10:40 Artificial intelligence in Diagnosis of Thyroid Cancer   ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 10:40~10:50 ÅäÀÇ  () 
È޽Ġ03-05 À̺¥Æ®È¦A&B 10:50~11:10 Coffee Break  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 11:10~12:10 Diagnostic, Prognostic and Predictive Factors in Differentiated Thyroid Carcinomas: From Morphology to Biomarker Studies  Ozgur Mete(Toronto General Hospital: University Health Network Canada) 
±âŸ 03-05 À̺¥Æ®È¦A&B 12:10~12:40 ÃÑȸ  () 
½Ä»ç 03-05 À̺¥Æ®È¦A&B 12:40~13:40 Á¡½É ½Ä»ç  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 13:40~14:20 ¹æ»ç¼º¿ä¿Àµå Ä¡·á¿Í 2Â÷¾Ï  ÀÌÀçÅÂ(°æºÏÀÇ´ë ÇÙÀÇÇаú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 14:20~14:40 NIRAF in Thyroid Surgery  ÀÌ°­´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 14:40~15:00 New Imaging Techniques (Photoaccoustic Image, Laser Speckle, Next USG)  ±èÁö¼ö(ºÎ»ê´ë ³ª³ë°úÇбâ¼ú´ë) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 15:00~15:20 Percutaneous Neuromonitoring  À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 15:20~15:30 ÅäÀÇ  () 
È޽Ġ03-05 À̺¥Æ®È¦A&B 15:30~15:50 Coffee Break  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 15:50~16:50 Serial Studies of Apatinib in Patients with Radioiodine Refractory Thyroid Cancer  Yansong Lin(Peking Union Medical College Hospital China) 
±âŸ 03-05 À̺¥Æ®È¦A&B 16:50~17:50 Topic Highlight  () 
±âŸ 03-05 À̺¥Æ®È¦D 08:30~09:40 Free Paper 3  () 
±âŸ 03-05 À̺¥Æ®È¦D 09:40~10:50 Free Paper 4  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 14:20~14:40 °©»ó¼± ÃÊÀ½ÆÄ ±Þ¿©È­  ÇѼö¿¬(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 14:40~15:00 ¼ö¼úÀå CCTV - º´ÇùÀÔÀå  ¼ÛÀçÂù(´ëÇѺ´¿øÇùȸ ºÎȸÀå) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 15:00~15:20 ¼ö¼úÀå CCTV - ÀÇÇùÀÔÀå  ±èÁ¾¹Î(´ëÇÑÀÇ»çÇùȸ º¸ÇèÀÌ»ç) 
Åä·Ð 03-05 À̺¥Æ®È¦D 15:20~15:30 ÅäÀÇ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°è¿¬¼ö°­Á : 2022-03-05
´ÙÀ½±Û ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼± ÃÊÀ½ÆÄ Hands-On Course : 2022-03-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 43 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 34 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 35 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 43 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 36 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 27 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 11 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 25 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 13 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 11 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 29 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 17 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 25 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 21 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷